| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.474 | 34.456 | 23.068 | 0 | 93.199 | 47.687 | 167.964 | 138.031 |
| Total Income - EUR | - | - | 10.474 | 34.456 | 23.069 | 0 | 93.227 | 47.687 | 167.964 | 138.218 |
| Total Expenses - EUR | - | - | 5.977 | 23.002 | 20.731 | 1.755 | 79.188 | 57.428 | 131.578 | 114.540 |
| Gross Profit/Loss - EUR | - | - | 4.497 | 11.454 | 2.338 | -1.755 | 14.039 | -9.741 | 36.386 | 23.678 |
| Net Profit/Loss - EUR | - | - | 4.253 | 11.109 | 2.100 | -1.755 | 13.105 | -10.149 | 34.787 | 19.774 |
| Employees | - | - | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Elisyomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 1.091 |
| Current Assets | - | - | 6.659 | 19.114 | 9.563 | 7.546 | 8.548 | 26.402 | 73.816 | 58.945 |
| Inventories | - | - | 868 | 1.890 | 625 | 614 | 1.950 | 5.010 | 4.968 | 4.540 |
| Receivables | - | - | 132 | 1.027 | 386 | 377 | 1.016 | 5.100 | 6.793 | 3.161 |
| Cash | - | - | 5.660 | 16.197 | 8.552 | 6.555 | 5.582 | 16.291 | 62.055 | 51.244 |
| Shareholders Funds | - | - | 4.297 | 11.152 | 9.400 | 7.467 | 20.407 | 10.321 | 45.077 | 32.915 |
| Social Capital | - | - | 44 | 43 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | - | - | 2.402 | 7.962 | 163 | 78 | -11.859 | 16.081 | 28.878 | 27.121 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Elisyomed S.r.l.